Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats

American Journal of Hypertension

Volumn 18, Issue 4, 2005, Pages 544-548

  Awad, Alaa S ^a   Webb, Randy L ^b   Carey, Robert M ^a   Siragy, Helmy M ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Angiotensin II; AT1 receptor; Diabetes mellitus; Kidney; Thromboxane

Indexed keywords

ALBUMIN; ANGIOTENSIN; STREPTOZOCIN; THROMBOXANE B2; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; HORMONE SYNTHESIS; INTERSTITIAL FLUID; KIDNEY INTERSTITIUM; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION;

EID: 17044387028     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.10.018     Document Type: Article

References (35)

1. A.B. Sobol, C. Watala The role of platelets in diabetes-related vascular complications Diabetes Res Clin Pract 50 2000 1 16
2. A. Lopez-Farre, L. Sanchez de Miguel, M. Monton, A. Jimenez, A. Lopez-Bloya, J. Gomez, J. Nunez, L. Rico, S. Casado Angiotensin II AT1 receptor antagonists and platelet activation Nephrol Dial Transplant 16 2001 45 49
3. C.S. Wilcox, W.J. Welch, H. Snellen Thromboxane mediates renal hemodynamic response to infused angiotensin II Kidney Int 40 1991 1090 1097
4. A.B. Glassman Platelet abnormalities in diabetes mellitus Ann Clin Lab Sci 23 1993 47 50
5. H.L. Keen, M.W. Brands, M.J. Smith, E.W. Shek, J.E. Hall Thromboxane is required for full expression of angiotensin hypertension in rats Hypertension 29 1997 310 314
6. K.D. Burns Angiotensin II and its receptors in the diabetic kidney Am J Kidney Dis 36 2000 449 467
7. H.M. Siragy, R.M. Carey The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′, 5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats J Clin Invest 97 1996 1978 1982
8. H.M. Siragy, R.M. Carey The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats J Clin Invest 100 1997 264 269
9. R. Vienet, J.M. Grognet, E. Ezan, D. Lecaque, G. Hamon, B. Corman Effect of chronic converting-enzyme inhibition on kidney function of senescent hypertensive rats J Cardiovasc Pharmacol 23 1994 S19 S25
10. H.M. Siragy, R.M. Carey Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model Hypertension 33 1999 1237 1242
11. F. Lellouche, A. Fradin, G. FitzGerald, J. Maclouf Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin Prostaglandins 40 1990 297 310
12. H.M. Siragy, M. de Gasparo, R.M. Carey Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats Hypertension 35 2000 1074 1077
13. H.M. Siragy, A. Awad, P. Abadir, R. Webb The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats Endocrinology 144 2003 2229 2233
14. S. Anderson, F.F. Jung, J.R. Inglefinger Renal renin-angiotensin system in diabetes Functional, immunohistochemical, and molecular biological correlations Am J Physiol 265 1993 F477 F486
15. M.W. Brands, S.M. Fitzgerald Blood pressure control early in diabetes a balance between angiotensin II and nitric oxide Clin Exp Pharmacol Physiol 29 2002 127 131
16. K. Jandeleit, J. Rumble, B. Jackson, M.E. Cooper Mesenteric vascular angiotensin-converting enzyme is increased in experimental diabetes mellitus Clin Exp Pharmacol Physiol 19 1992 343 347
17. J. Zimpelmann, D. Kumar, D.Z. Levine, G. Wehbi, J.D. Imig, L.G. Navar, K.D. Burns Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat Kidney Int 58 2000 2320 2330
18. P. Muller, T. Cohen, M. de Gasparo, A. Sioufi, A. Racine-Poon, H. Howald Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjectsEur J Clin Pharmacol 47 1994 231 245
19. D.J. Campbell, A. Kladis, A.-M. Duncan Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides Hypertension 23 1994 439 449
20. M.W. Brands, T.E. Hopkins Poor glycemic control induced hypertension in diabetes mellitus Hypertension 27 1996 753 759
21. J.A. Miller Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus J Am Soc Nephrol 10 1999 1778 1785
22. R. Tatchum-Talom, V. Gopalakrishnan, J.R. McNeill Radiotelemetric monitoring of blood pressure and mesenteric arterial bed responsiveness in rats with streptozotocin-induced diabetes Can J Physiol Pharmacol 78 2000 721 728
23. M.W. Brands, S.M. Fitzgerald, W.H. Hewitt, A.E. Hailman Decreased cardiac output at the onset of diabetes renal mechanisms and peripheral vasoconstriction Am J Physiol 278 2000 E917 E924
24. B.J. Ballermann, D.J. Levenson, B.M. Brenner Renin, angiotensin, kinins, prostaglandins, and leukotriens B.M. Brenner F.C. Rector The Kidney 1986 WB Saunders Philadelphia 281 340
25. M. Schambelan, S. Blake, J. Sraer, M. Bens, M.P. Nivez, F. Wahbe Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus J Clin Invest 75 1985 404 412
26. P.A. Craven, M.A. Caines, F.R. DeRubertis Sequential alteration in glomerular prostaglandin and thromboxane synthesis in diabetic rats relationship to hyperfiltration of early diabetes Metabolism 36 1987 95 103
27. W.J. Welch, C.S. Wilcox, K.R. Dunbar Modulation of renin by thromboxane studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic Am J Physiol 257 1989 F554 F560
28. J. Quilley, J.C. McGiff Influence of insulin on urinary eicosanoid excretion in rats with experimental diabetes mellitus J Pharmacol Exp Ther 238 1986 606 611
29. M. Small, J.T. Douglas, G.D. Lowe, A.C. MacCuish, C.D. Forbes Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitus Haemostasis 6 1986 417 423
30. C. Corriu, S. Bernard, C. Schott, J.C. Stoclet Effects of losartan on contractile responses of conductance and resistance arteries from rats J Cardiovasc Pharmacol 26 1995 688 692
31. P. Li, C.M. Ferrario, K.B. Brosnihan Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries J Pharmacol Exp Ther 281 1997 1065 1070
32. K. Uriu, K. Kaizu, O. Hashimoto, N. Komine, S. Etho Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats Kidney Int 45 1994 794 802
33. F. Freeman, M.L. Ruehr, R.V. Dorman ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells Am J Physiol 274 1998 C282 C288
34. R. Komers, J.N. Lindsley, T.T. Oyama, W.E. Schutzer, J.F. Reed, S.L. Mader, S. Anderson Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes J Clin Invest 107 2001 889 898
35. P. Harding, D.H. Sigmon, M.E. Alfie, P.L. Huang, M.C. Fishman, W.H. Beierwaltes, O.A. Carretero Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet Hypertension 29 1997 297 302